Arcus Biosciences, Inc. (RCUS)

24.44 -0.79 (-3.13%) USD  |  NYSE  |  Oct 02, 16:00
24.06 -0.38 (-1.55%) After-Hours: 20:00
More

Arcus Biosciences EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for RCUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS LT Growth Estimates Data

View and export this data back to 2022. Start Trial.
Date Value
November 18, 2022 --

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
AVITA Medical, Inc. Upgrade
Iovance Biotherapeutics, Inc. --
Editas Medicine, Inc. --
Recursion Pharmaceuticals, Inc. --